Varian to launch BrachyVision Acuros

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Varian Medical Systems will introduce BrachyVision Acuros, a system that allows clinicians to calculate patient doses for brachytherapy treatments, at the GEC-ESTRO exhibition in Porto, Portgual, on May 14-16.

Acuros, developed by Transpire, is a radiotherapy-specific rewrite of the software product Attila, and Varian is working with Transpire to bring the benefits of this calculation method to the radiation oncology field, according to the Palo Alto, Calif.-based company.

BrachyVision Acuros uses a technique called a Grid-Based Boltzmann Solver (GBBS), which has been added to Varian's latest brachytherapy treatment planning software offering, BrachyVision 8.8. The full system will be demonstrated for the first time at GEC-ESTRO.  

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.